Samuel Galster

Dr. Galster received his PhD in Medicinal Chemistry in 2021 from the University at Buffalo. His research focused on the synthesis of potential small molecule cancer therapeutics and the development of novel organometallic reactions. He then joined UNC to work under the guidance of Dr. Qisheng Zhang to develop small molecule modulators for the phospholipase C-gamma (PLC-g) isozymes. Dr. Galster was appointed to the CCNTP in July 2022 to expand upon these efforts with nanotechnology and to develop a high-throughput assay that combines a liposome-based enzymatic reaction with detection through surface-based mass spectrometry to identify selective PLC-g inhibitors.